1Lena Ros Asmnndsdottir,Helga Erlendsdottir,and Maguus Gottfredsson. Increasing incidence of Candida results from a 20-year nationwide study in Iceland [J].JCM,2002,40:3489-3492.
2Richards MJ,Edwards JR,Culver DH,et al.Nosocomial infections medical intentive care units in the United States[J].Crit Care Med,1999,27:887.
4Pfaller MA,Jones RN,Doern GV,et al. Oral transmission of Candida albicans between parterns in HIV-infected couples could contribute to dissemination of fluconazole-resistant isolates [J].Antimicrob Agents Chemother,2000,44 (3):747-751.
5Magaldi S,Mata S,Haitung C ,et al. In vitro susceptibility of 137 Candida SPP.isolates from HIV positive patients to several anti-fungal drugs[J].Mycopathologia,2001,149(2):63-68.
6Doczi I,Dose E,Hajdu E,et al. Aetiology and antifungal susceptibility of yeast bloodstream infections in a Hungarian university hospital between 1996 and 2000 [J].J Med Microbiol, 2002,51 ( 8 ) :677-681.
7Perea S,Lopez-Ribot JL,Kipkpatrick WR,et al.Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconasole resistance isolated from HIV patients[J].Antimicrob Agents Chemother,2001,45 (10):2676-2684.
8Wirsching S,Michel S,Morschhauser J,et al.Targetet gene disruption in Candida albicans wilde-type strains:the role of the MDR1 gene in fluconazole resistance of clinical Candida albicans isolate [J].Mol Microbiol,2000,36(4):856-865.
9Aterson PJ,Mcwhinney PH,Potter M,et al.The combination of oral amphotericin B with azoles prevents the emergence of resistant Candida species in nertropenic patients [J].Br J Haematol,2001,112(1):175-180.
